Lpl Financial LLC Biogen Inc. Transaction History

Lpl Financial LLC

$218 Billion
Q3 2024

A detailed history of Lpl Financial LLC transactions in Biogen Inc. stock. As of the latest transaction made, Lpl Financial LLC holds 44,391 shares of BIIB stock, worth $7.01 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

44,391

Previous 51,498 13.8%

Holding current value

$7.01 Million

Previous $11.9 Million 27.93%

% of portfolio

0.0%

Previous 0.01%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 08, 2024	SELL	$189.07 - $236.8 $1.34 Million - $1.68 Million	-7,107 Reduced 13.8%	44,391 $8.6 Million
Q2 2024 Aug 07, 2024	BUY	$190.52 - $236.72 $635,003 - $788,987	3,333 Added 6.92%	51,498 $11.9 Million
Q1 2024 May 10, 2024	BUY	$212.02 - $267.71 $656,201 - $828,562	3,095 Added 6.87%	48,165 $10.4 Million
Q4 2023 Feb 14, 2024	SELL	$222.59 - $267.94 $1.28 Million - $1.54 Million	-5,740 Reduced 11.3%	45,070 $11.7 Million
Q3 2023 Nov 13, 2023	BUY	$253.3 - $285.89 $2.22 Million - $2.51 Million	8,781 Added 20.89%	50,810 $13.1 Million
Q2 2023 Jul 31, 2023	SELL	$275.25 - $318.06 $137,625 - $159,030	-500 Reduced 1.18%	42,029 $12 Million
Q1 2023 May 10, 2023	SELL	$256.56 - $292.34 $5,644 - $6,431	-22 Reduced 0.05%	42,529 $11.8 Million
Q4 2022 Feb 07, 2023	BUY	$252.44 - $306.72 $385,223 - $468,054	1,526 Added 3.72%	42,551 $11.8 Million
Q3 2022 Nov 14, 2022	SELL	$194.69 - $268.46 $932,175 - $1.29 Million	-4,788 Reduced 10.45%	41,025 $11 Million
Q2 2022 Aug 12, 2022	SELL	$187.54 - $223.02 $53,073 - $63,114	-283 Reduced 0.61%	45,813 $9.34 Million
Q1 2022 May 16, 2022	BUY	$193.77 - $244.14 $21,702 - $27,343	112 Added 0.24%	46,096 $9.71 Million
Q4 2021 Feb 14, 2022	SELL	$223.92 - $287.77 $732,890 - $941,871	-3,273 Reduced 6.64%	45,984 $11 Million
Q3 2021 Nov 15, 2021	BUY	$282.99 - $369.05 $3.2 Million - $4.18 Million	11,320 Added 29.84%	49,257 $13.9 Million
Q2 2021 Aug 13, 2021	SELL	$259.0 - $414.71 $889,147 - $1.42 Million	-3,433 Reduced 8.3%	37,937 $13.1 Million
Q1 2021 May 14, 2021	BUY	$242.95 - $284.63 $375,357 - $439,753	1,545 Added 3.88%	41,370 $11.6 Million
Q4 2020 Feb 12, 2021	BUY	$236.26 - $355.63 $647,116 - $974,070	2,739 Added 7.39%	39,825 $9.75 Million
Q3 2020 Nov 09, 2020	BUY	$264.77 - $305.71 $1.09 Million - $1.26 Million	4,110 Added 12.46%	37,086 $10.5 Million
Q2 2020 Aug 13, 2020	BUY	$258.66 - $342.55 $457,310 - $605,628	1,768 Added 5.67%	32,976 $8.82 Million
Q1 2020 May 14, 2020	SELL	$268.85 - $341.04 $629,646 - $798,715	-2,342 Reduced 6.98%	31,208 $9.87 Million
Q4 2019 Feb 14, 2020	SELL	$220.06 - $304.07 $84,282 - $116,458	-383 Reduced 1.13%	33,550 $9.96 Million
Q3 2019 Nov 13, 2019	SELL	$217.44 - $243.88 $5,218 - $5,853	-24 Reduced 0.07%	33,933 $7.9 Million
Q2 2019 Aug 09, 2019	SELL	$219.29 - $241.72 $2.46 Million - $2.71 Million	-11,202 Reduced 24.81%	33,957 $7.94 Million
Q1 2019 May 08, 2019	SELL	$216.71 - $338.96 $5,417 - $8,474	-25 Reduced 0.06%	45,159 $10.7 Million
Q4 2018 Feb 07, 2019	BUY	$278.5 - $352.75 $701,263 - $888,224	2,518 Added 5.9%	45,184 $13.6 Million
Q3 2018 Nov 14, 2018	SELL	$293.51 - $383.83 $79,834 - $104,401	-272 Reduced 0.63%	42,666 $15.1 Million
Q2 2018 Aug 14, 2018	SELL	$257.52 - $306.91 $1.29 Million - $1.54 Million	-5,013 Reduced 10.45%	42,938 $12.5 Million
Q1 2018 May 15, 2018	SELL	$260.13 - $367.91 $762,441 - $1.08 Million	-2,931 Reduced 5.76%	47,951 $13.1 Million
Q4 2017 Feb 14, 2018	BUY	$307.64 - $344.58 $1.69 Million - $1.9 Million	5,501 Added 12.12%	50,882 $16.2 Million
Q3 2017 Nov 14, 2017	BUY	$281.15 - $329.69 $6.14 Million - $7.2 Million	21,847 Added 92.83%	45,381 $14.2 Million
Q2 2017 Aug 14, 2017	BUY	N/A	23,534	23,534 $6.39 Million

Others Institutions Holding BIIB

# of Institutions

1,036

Shares Held

126M

Call Options Held

1.13M

Put Options Held

1.43M

View Full List

About BIOGEN INC.

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $22.7B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

More about BIIB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Lpl Financial LLC, based on Form 13F filings with the SEC.

News

Stay updated on Lpl Financial LLC with notifications on news.

Account

Lpl Financial LLC Biogen Inc. Transaction History